These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36477451)

  • 21. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
    Liu XL; Pan WG; Li KL; Mao YJ; Liu SD; Zhang RM
    Cancer Biother Radiopharm; 2020 Jun; 35(5):377-386. PubMed ID: 31971830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autophagy is a major mechanism for the dual effects of curcumin on renal cell carcinoma cells.
    Deng Q; Liang L; Liu Q; Duan W; Jiang Y; Zhang L
    Eur J Pharmacol; 2018 May; 826():24-30. PubMed ID: 29501864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-204 inhibits the proliferation and invasion of renal cell carcinoma by inhibiting RAB22A expression.
    Xiong F; Liu K; Zhang F; Sha K; Wang X; Guo X; Huang N
    Oncol Rep; 2016 May; 35(5):3000-8. PubMed ID: 26883716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpressed lncRNA FTX promotes the cell viability, proliferation, migration and invasion of renal cell carcinoma via FTX/miR‑4429/UBE2C axis.
    Chen Z; Zhang M; Lu Y; Ding T; Liu Z; Liu Y; Zhou Z; Wang L
    Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35866591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Silence of circBANP increases radiosensitivity of colorectal cancer cells and inhibits growth of subcutaneous xenografts by up-regulating miR-338-3p expression].
    Xie Y; Liu JB; Li JM; Zhang C; Lu CX; Wen ZJ
    Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):533-540. PubMed ID: 34034472
    [No Abstract]   [Full Text] [Related]  

  • 26. miR-130b Promotes Sunitinib Resistance through Regulation of PTEN in Renal Cell Carcinoma.
    Sekino Y; Sakamoto N; Sentani K; Oue N; Teishima J; Matsubara A; Yasui W
    Oncology; 2019; 97(3):164-172. PubMed ID: 31195398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-30d-5p suppresses proliferation and autophagy by targeting ATG5 in renal cell carcinoma.
    Liang L; Yang Z; Deng Q; Jiang Y; Cheng Y; Sun Y; Li L
    FEBS Open Bio; 2021 Feb; 11(2):529-540. PubMed ID: 33145996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA XIST regulates miR-106b-5p/P21 axis to suppress tumor progression in renal cell carcinoma.
    Sun K; Jia Z; Duan R; Yan Z; Jin Z; Yan L; Li Q; Yang J
    Biochem Biophys Res Commun; 2019 Mar; 510(3):416-420. PubMed ID: 30717973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-10a suppresses cell metastasis by targeting BDNF and predicted patients survival in renal cell carcinoma.
    Liu Y; Qi L; Zhang K; Wang F
    J BUON; 2021; 26(1):250-258. PubMed ID: 33721459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hsa_circ_0035483 sponges hsa-miR-335 to promote the gemcitabine-resistance of human renal cancer cells by autophagy regulation.
    Yan L; Liu G; Cao H; Zhang H; Shao F
    Biochem Biophys Res Commun; 2019 Oct; 519(1):172-178. PubMed ID: 31492499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin inhibits lipopolysaccharide-induced proximal renal tubular epithelial cell death by regulating ADAMTS18 methylation and AKT/Notch pathways.
    Xu B; Zhang JE; Ye L; Yuan CW
    Arch Med Sci; 2023; 19(6):1822-1831. PubMed ID: 38058716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway.
    Xu X; Wu J; Li S; Hu Z; Xu X; Zhu Y; Liang Z; Wang X; Lin Y; Mao Y; Chen H; Luo J; Liu B; Zheng X; Xie L
    Mol Cancer; 2014 May; 13():109. PubMed ID: 24886554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-212-5p inhibits the malignant behavior of clear cell renal cell carcinoma cells by targeting TBX15.
    Deng JH; Zheng GY; Li HZ; Ji ZG
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10699-10707. PubMed ID: 31858538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-33a inhibits cell growth in renal cancer by downregulation of MDM4 expression.
    Jiang K; Sun F; Zhu J; Luo G; Ban Y; Zhang P
    Mol Genet Genomic Med; 2019 Aug; 7(8):e833. PubMed ID: 31250570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.
    Wu C; Zhang J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway.
    Fu JH; Yang S; Nan CJ; Zhou CC; Lu DQ; Li S; Mu HQ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):351-357. PubMed ID: 29424922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-216b Post-Transcriptionally Downregulates Oncogene KRAS and Inhibits Cell Proliferation and Invasion in Clear Cell Renal Cell Carcinoma.
    Wang Y; Dong D; Jiang S; Zhang E; Zheng W; Mao L; Li W; Zhou J; Fan L; Cheng R; Li Z; Fang Z; Gui Y; Li X
    Cell Physiol Biochem; 2018; 49(5):1755-1765. PubMed ID: 30231239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR‑133b affects cell proliferation, invasion and chemosensitivity in renal cell carcinoma by inhibiting the ERK signaling pathway.
    Xu Y; Ma Y; Liu XL; Gao SL
    Mol Med Rep; 2020 Jul; 22(1):67-76. PubMed ID: 32377748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circular RNA circMTO1 suppressed the progression of renal cell carcinoma progression by sponging miR-211 and miR-204.
    Wang K; Lin X
    Mamm Genome; 2022 Sep; 33(3):517-524. PubMed ID: 35092479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long intergenic non-coding RNA 1939 eliminates proliferation and migration of human renal cell carcinoma (RCC) cells by down-regulation of miR-154.
    Zhang R; Zhang W; Xu B; Lv C; Hou J; Zhang G
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):695-702. PubMed ID: 32138544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.